Vanguard Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,588,032
Closed -$15.8M 4704
2021
Q3
$15.8M Sell
2,588,032
-15,256
-0.6% -$95.1K ﹤0.01% 2991
2021
Q2
$21.4M Buy
2,603,288
+179,271
+7% +$1.52M ﹤0.01% 2803
2021
Q1
$21.7M Buy
2,424,017
+52,554
+2% +$602K ﹤0.01% 2743
2020
Q4
$27.4M Buy
2,371,463
+69,588
+3% +$809K ﹤0.01% 2486
2020
Q3
$24M Buy
2,301,875
+27,078
+1% +$332K ﹤0.01% 2370
2020
Q2
$29.9M Buy
2,274,797
+507,978
+29% +$5.27M ﹤0.01% 2240
2020
Q1
$13.9M Sell
1,766,819
-6,318
-0.4% -$95.2K ﹤0.01% 2458
2019
Q4
$36.7M Sell
1,773,137
-13,611
-0.8% -$230K ﹤0.01% 2247
2019
Q3
$24.5M Sell
1,786,748
-92,780
-5% -$1.1M ﹤0.01% 2392
2019
Q2
$23.1M Buy
1,879,528
+178,040
+10% +$2.05M ﹤0.01% 2440
2019
Q1
$21.2M Buy
1,701,488
+64,795
+4% +$866K ﹤0.01% 2483
2018
Q4
$18.5M Buy
1,636,693
+17,581
+1% +$276K ﹤0.01% 2481
2018
Q3
$30.3M Buy
1,619,112
+18,323
+1% +$421K ﹤0.01% 2381
2018
Q2
$41.4M Buy
1,600,789
+50,582
+3% +$1.31M ﹤0.01% 2226
2018
Q1
$34.7M Buy
1,550,207
+91,399
+6% +$2.23M ﹤0.01% 2256
2017
Q4
$36.5M Buy
1,458,808
+319,874
+28% +$7.83M ﹤0.01% 2226
2017
Q3
$27.5M Buy
1,138,934
+84,470
+8% +$1.99M ﹤0.01% 2342
2017
Q2
$21.3M Buy
1,054,464
+59,143
+6% +$1.23M ﹤0.01% 2422
2017
Q1
$26.8M Buy
995,321
+32,479
+3% +$663K ﹤0.01% 2313
2016
Q4
$18.3M Buy
962,842
+126,285
+15% +$2.41M ﹤0.01% 2458
2016
Q3
$16.3M Buy
836,557
+140,406
+20% +$2.37M ﹤0.01% 2448
2016
Q2
$10.4M Buy
696,151
+205,327
+42% +$2.58M ﹤0.01% 2629
2016
Q1
$4.51M Buy
490,824
+44,210
+10% +$536K ﹤0.01% 3013
2015
Q4
$8.61M Buy
446,614
+9,613
+2% +$167K ﹤0.01% 2723
2015
Q3
$6.49M Buy
437,001
+37,258
+9% +$874K ﹤0.01% 2843
2015
Q2
$8.75M Buy
399,743
+191,373
+92% +$3.86M ﹤0.01% 2749
2015
Q1
$4.69M Buy
208,370
+82,313
+65% +$1.91M ﹤0.01% 3027
2014
Q4
$2.54M Buy
126,057
+96,315
+324% +$1.75M ﹤0.01% 3190
2014
Q3
$543K Buy
29,742
+9,139
+44% +$132K ﹤0.01% 3688
2014
Q2
$278K Buy
+20,603
New +$281K ﹤0.01% 3800